Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 7, 2026
Baudax Bio Market Cap
Baudax Bio has a market cap or net worth of $52 as of October 9, 2026. It is the 53,002nd most valuable company in the world and the 9,026th biggest in the United States.
Market Cap
52.00
Enterprise Value
n/a
Revenue
1.27M
Global Rank
Country Rank
#9,026 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 18, 2019, Baudax Bio's market cap has decreased from 54.92M to 52.00, a decrease of -100.00%. That is a compound annual growth rate of -86.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 52.00 | - |
| Dec 30, 2025 | 52.00 | - |
| Dec 31, 2024 | 52.00 | -100.00% |
| Dec 29, 2023 | 1.15M | -34.59% |
| Dec 30, 2022 | 1.76M | -90.48% |
| Dec 31, 2021 | 18.54M | -30.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardax | 83.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Better Therapeutics | 55.00 |
| Panacos Pharmaceuticals | 54.00 |
| Iterum Therapeutics | 53.00 |
| Core One Labs | 47.00 |